Biorestorative Therapies, Inc.

BRTX·NASDAQ·$0.25Share Price as of 11/2·$2MMarket Cap as of 11/2

Financials

10-QQ1 ended 03/31/2605/14/26 10-KFY 202503/26/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/12/25 10-QQ1 ended 03/31/2505/14/25

Disclosures

8-KCurrent report10/09/26 8-KCurrent report09/11/26 8-K/ACurrent report (amended)09/10/26 8-KCurrent report09/02/26 8-KCurrent report09/02/26

Prospectuses and Registrations

424B3Prospectus04/30/26 POS AMPost-effective amendment04/27/26 POS AMPost-effective amendment04/20/26 424B4Prospectus02/13/26 S-1/ARegistration statement (amended)02/10/26

Proxies

DEF 14ADefinitive proxy04/13/26 PRE 14APreliminary proxy04/03/26 DEF 14ADefinitive proxy08/08/25 DEF 14ADefinitive proxy08/08/24 DEF 14ADefinitive proxy08/04/23

Ownership

SC 13G/ABeneficial ownership (amended)08/03/26 Form 3Initial insider ownership07/30/26 Form 3Initial insider ownership07/24/26 Form 3Initial insider ownership06/18/26 Form 3Initial insider ownership06/18/26

Other

NT 10-QLate filing notification (10-Q)08/14/26 EFFECTRequest for effectiveness04/28/26 EFFECTRequest for effectiveness02/11/26 CORRESPCorrespondence with the SEC02/10/26 DRSDRS12/19/25